Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3175 of 3284 entries
View as:

A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK

Phase: N/A Priority: Normal
NCT ID: NCT06269484 Org: User:
Start: 02/15/24 End: 12/11/24 Due: 12/11/25

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Phase: N/A Priority: Normal
NCT ID: NCT06455449 Org: User:
Start: 06/20/24 End: 08/04/28 Due: 08/04/29

Validation of the Spanish Version of the Clinically Useful Depression Outcome Scale (CUDOS) Scale

Phase: N/A Priority: Normal
NCT ID: NCT01360307 Org: User:
Start: 06/30/11 End: 11/30/11 Due: 11/30/12

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06989112 Org: User:
Start: 03/27/25 End: 02/20/31 Due: 02/20/32

Hypoglycemia: Physician and Patient Perspectives

Phase: N/A Priority: Normal
NCT ID: NCT01176656 Org: User:
Start: 09/30/10 End: 12/31/10 Due: 12/31/11

A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD5462 and the Absolute Bioavailability of AZD5462

Phase: N/A Priority: Normal
NCT ID: NCT06989983 Org: User:
Start: 05/19/25 End: 07/01/25 Due: 07/01/26

A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease

Phase: N/A Priority: Normal
NCT ID: NCT04711252 Org: User:
Start: 01/28/21 End: 02/01/29 Due: 02/01/30

Pan-European Survey on the Under Treatment of Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00542867 Org: User:
Start: 01/31/06 End: 11/30/07 Due: 11/30/08

Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha Antagonist

Phase: N/A Priority: Normal
NCT ID: NCT01197755 Org: User:
Start: 09/30/10 End: 02/28/13 Due: 02/28/14

To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02056392 Org: User:
Start: 03/31/14 End: 08/31/14 Due: 08/31/15

Study to Assess MEDI -578 in Patients With Osteoarthritis (OA) of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT01072591 Org: User:
Start: 02/28/10 End: 09/30/10 Due: 09/30/11

Real-World Outcomes in COPD Patients Starting Trixeo (Budesonide/Glycopyrronium/Formoterol) in Spain.

Phase: N/A Priority: Normal
NCT ID: NCT06321731 Org: User:
Start: 07/02/24 End: 12/16/24 Due: 12/16/25

A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT06168409 Org: User:
Start: 03/01/24 End: 09/05/25 Due: 09/05/26

A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition

Phase: N/A Priority: Normal
NCT ID: NCT05061134 Org: User:
Start: 08/31/22 End: 11/02/26 Due: 11/02/27

A Phase 1 Study of AZD9833 in Japanese Women With ER Positive, HER2 Negative Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04541433 Org: User:
Start: 09/29/20 End: 12/31/25 Due: 12/31/26

Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.

Phase: N/A Priority: Normal
NCT ID: NCT03218683 Org: User:
Start: 08/02/17 End: 10/08/21 Due: 10/08/22

A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)

Phase: N/A Priority: Normal
NCT ID: NCT01347580 Org: User:
Start: 09/30/11 End: 11/30/13 Due: 11/30/14

Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg

Phase: N/A Priority: Normal
NCT ID: NCT00918138 Org: User:
Start: 08/31/09 End: 05/31/10 Due: 05/31/11

Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments

Phase: N/A Priority: Normal
NCT ID: NCT02282020 Org: User:
Start: 02/06/15 End: 07/19/22 Due: 07/19/23

Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)

Phase: N/A Priority: Normal
NCT ID: NCT05251909 Org: User:
Start: 01/18/22 End: 02/13/24 Due: 02/13/25

A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA

Phase: N/A Priority: Normal
NCT ID: NCT03316131 Org: User:
Start: 10/25/17 End: 07/19/18 Due: 07/19/19

LatInamerican Vaccine Effectiveness Against Hospitalizations Due to Circulating COVID-19 VoC RWE Study

Phase: N/A Priority: Normal
NCT ID: NCT05282017 Org: User:
Start: 02/01/22 End: 04/19/23 Due: 04/19/24

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Phase: N/A Priority: Normal
NCT ID: NCT00536796 Org: User:
Start: 09/30/07 End: 12/31/07 Due: 12/31/08

Double-blind Placebo-controlled 2-part Study Assessing the Safety, Tolerability and PK of AZD1386 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00945178 Org: User:
Start: 08/31/09 End: 09/30/09 Due: 09/30/10

A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)

Phase: N/A Priority: Normal
NCT ID: NCT05202262 Org: User:
Start: 01/12/22 End: 02/26/25 Due: 02/26/26